/
© 2026 RiffOn. All rights reserved.
  1. TBPN
  2. OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua
OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN · Oct 6, 2025

OpenAI's DevDay debuts Agent Builder as a massive AMD deal escalates the AI CapEx war, signaling a new era of circular financing & infrastructure.

AI's Circular "Vendor Financing" Deals Echo the Risky Dot-Com Bubble Era

The current trend of AI infrastructure providers investing in their largest customers, who then use that capital to buy their products, mirrors the risky vendor financing seen in the dot-com bubble. This creates circular capital flows and potential systemic risk.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

Appetite-Suppressing Drugs Like Ozempic Fail in the Pet Market Due to Emotional Factors

A drug that reduces appetite is a poor product for dogs. A dog's excitement for food is a major source of joy and a core part of the owner-pet relationship. Removing this makes the dog seem "grumpy" and diminishes the perceived bond, a critical failure for a consumer pet product.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

Apple's iMessage Lock-In, Not Manufacturing, Is OpenAI's Biggest Hardware Hurdle

The true challenge for the rumored OpenAI hardware isn't production, but breaking through Apple's powerful ecosystem effects, particularly iMessage integration. User adoption of a new, screenless form factor is another major, unsolved problem that has stumped previous startups.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

OpenAI's Partnership Spree Intentionally Creates a "Too Big to Fail" Safety Net

By inking deals with NVIDIA, AMD, and major cloud providers, OpenAI is making its survival integral to the entire tech ecosystem. If OpenAI faces financial trouble, its numerous powerful partners will be heavily incentivized to provide support, effectively making it too big to fail.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

Lack of Biological Data, Not Flawed AI Models, Hinders AI Drug Discovery

The bottleneck for AI in drug development isn't the sophistication of the models but the absence of large-scale, high-quality biological data sets. Without comprehensive data on how drugs interact within complex human systems, even the best AI models cannot make accurate predictions.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

OpenAI's Chip Deals Reveal a Market "Premium" for NVIDIA and a "Discount" for AMD

OpenAI's deal structures highlight the market's perception of chip providers. NVIDIA commanded a direct investment from OpenAI to secure its chips (a premium). In contrast, AMD had to offer equity warrants to OpenAI to win its business (a discount), reflecting their relative negotiating power.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

Animal Health FDA Rules Allow Market Exclusivity for Repurposed Generic Drugs

The FDA incentivizes animal drug development by granting years of market exclusivity to companies that prove a generic human drug works for a novel use in animals. This avoids the "aspirin problem" in human medicine, where no one will fund trials for off-patent drugs because they can't be profitably marketed.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

OpenAI's Agent Builder May Create a "Prosumer" Tier with Consumption-Based Pricing

OpenAI's Agent Builder could establish a middle market between free, ad-supported consumers and large enterprise API users. This "prosumer" tier would consist of power users willing to pay based on their consumption of advanced, automated workflows, creating a new revenue stream.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

AI Data Centers Will Shift to "Behind-the-Meter" On-Site Power Generation

The public power grid cannot support the massive energy needs of AI data centers. This will force a shift toward on-site, "behind-the-meter" power generation, likely using natural gas, where data centers generate their own power and only "sip" from the grid during off-peak times.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

Big Tech's Corporate Debt Will Fuel the Next Phase of the AI Arms Race

Unlike past tech booms funded by venture capital, the next wave of AI investment will come from hyperscalers like Google and Meta leveraging their pristine balance sheets to take on massive corporate debt. Their capacity to raise capital this way dwarfs the entire VC ecosystem, enabling unprecedented spending.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago

OpenAI's Sora 2 API Release Signals Low Confidence in Building a Standalone Social Network

By allowing any developer to integrate its best video model via API, OpenAI is likely signaling it doesn't believe it can build a dominant, self-contained social video platform. A company aiming to create a new TikTok would maintain exclusivity over its core technology to maximize its competitive advantage.

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua thumbnail

OpenAI–AMD Deal, DevDay Reactions, xAI’s Memphis Datacenter | Doug O'Laughlin, Celine Halioua

TBPN·4 months ago